These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 30872272)
1. Mixed-phenotype acute leukemia with t(4;11)(q21;q23) Liu H Blood; 2019 Mar; 133(11):1265. PubMed ID: 30872272 [No Abstract] [Full Text] [Related]
2. The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features. Ragusa D; Makarov EM; Britten O; Moralli D; Green CM; Tosi S Cancer Rep (Hoboken); 2019 Oct; 2(5):e1207. PubMed ID: 32721124 [TBL] [Abstract][Full Text] [Related]
3. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis. Haddox CL; Mangaonkar AA; Chen D; Shi M; He R; Oliveira JL; Litzow MR; Al-Kali A; Hogan WJ; Elliott MA Blood Cancer J; 2017 Sep; 7(9):e607. PubMed ID: 29016570 [No Abstract] [Full Text] [Related]
4. A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid Leukemia. Capela de Matos RR; Ney Garcia DR; Othman MAK; Moura Ferreira G; Melo JB; Carreira IM; Meyer C; Marschalek R; Costa ES; Land MGP; Liehr T; Ribeiro RC; Silva MLM Cytogenet Genome Res; 2019; 157(4):213-219. PubMed ID: 30974445 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT. Esteve J; Giebel S; Labopin M; Czerw T; Wu D; Volin L; Socié G; Yakoub-Agha I; Maertens J; Cornelissen JJ; Pigneux A; Shimoni A; Schwerdtfeger R; Labussière-Wallet H; Russell N; Schattenberg A; Chevallier P; Koza V; Foà R; Schmid C; Peric Z; Mohty M; Nagler A Leukemia; 2021 Aug; 35(8):2232-2242. PubMed ID: 33542481 [TBL] [Abstract][Full Text] [Related]
6. First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia. Tandon S; Shago M; Davidson S; Kanwar N; Fuligni F; Shlien A; Whitlock J; Villani A; Abla O Cancer Genet; 2020 Oct; 248-249():31-33. PubMed ID: 32992102 [TBL] [Abstract][Full Text] [Related]
10. It takes two-to-leukemia: about addictions and requirements. Marschalek R Leuk Res; 2011 Mar; 35(3):424-5. PubMed ID: 21074267 [No Abstract] [Full Text] [Related]
11. Genetic and Epigenetic Characterization of a Discordant Russo A; Viberti C; Mareschi K; Casalone E; Guarrera S; Birolo G; Cazzaniga G; Corral L; Trentin L; Basso G; Fagioli F; Matullo G Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575904 [TBL] [Abstract][Full Text] [Related]
12. A case of pediatric acute myeloid leukemia with t(11;16)(q23;q24) leading to a novel KMT2A-USP10 fusion gene. Zerkalenkova E; Lebedeva S; Kazakova A; Baryshev P; Meyer C; Marschalek R; Novichkova G; Maschan M; Maschan A; Olshanskaya Y Genes Chromosomes Cancer; 2018 Oct; 57(10):522-524. PubMed ID: 30107050 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous involvement of 11q23 translocation resulting in chimeric MLL-AFF1 and a second translocation [t (9;21) (p13; p11.2)] in an infant acute lymphoblastic leukemia patient at relapse: A case report. Liu G; Lu X; Kim YM; Wang X; Li S; Liu Y Medicine (Baltimore); 2018 May; 97(21):e10874. PubMed ID: 29794792 [TBL] [Abstract][Full Text] [Related]
14. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene. Szotkowski T; Jarošová M; Zimmermannová O; Meyer C; Marschalek R; Zuna J; Hubáček J; Indrák K Cancer Genet; 2015 Dec; 208(12):610-4. PubMed ID: 26556690 [TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of adult t(4;11)(q21;q23)-associated acute lymphoblastic leukemia reveals a different signature from pediatric cases. De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Basinko A; Morel F; De Braekeleer M Anticancer Res; 2012 Sep; 32(9):3893-9. PubMed ID: 22993334 [TBL] [Abstract][Full Text] [Related]
16. Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1". da Fonseca Bastos ACS; da Silva Rezende AC; Ferreira LB; Blunck CB; Pombo-de-Oliveira MS; Emerenciano M; Gimba ERP Leuk Res; 2020 Apr; 91():106316. PubMed ID: 32114371 [No Abstract] [Full Text] [Related]
17. Complex three-way translocation involving MLL, ELL, RREB1, and CMAHP genes in an infant with acute myeloid leukemia and t(6;19;11)(p22.2;p13.1;q23.3). Tuborgh A; Meyer C; Marschalek R; Preiss B; Hasle H; Kjeldsen E Cytogenet Genome Res; 2013; 141(1):7-15. PubMed ID: 23735562 [TBL] [Abstract][Full Text] [Related]
18. Acute myelocytic leukemia with t(11;17)(q23;q12-q21) involves a fusion of MLL and AF17. Moore SD; Strehl S; Dal Cin P Cancer Genet Cytogenet; 2005 Feb; 157(1):87-9. PubMed ID: 15676155 [No Abstract] [Full Text] [Related]
19. Novel MLL/KMT2A-MON2 fusion in a child with therapy-related acute myeloid leukemia after treatment for acute promyelocytic leukemia. Gong Y; Wang M; Shen H; Chen Y; Cen J; Yin X; Yao L Mol Carcinog; 2021 Nov; 60(11):721-725. PubMed ID: 34236108 [TBL] [Abstract][Full Text] [Related]
20. A translocation in acute lymphoblastic leukemia that cytogenetically mimics the recurrent MLL-AFF1 translocation and fuses SEPT11 to MLL. Stevens SJ; Meers LE; Albrechts JC; Mebis-Verhees K; Bos GM; Engelen JJ; Janssen JW Cancer Genet Cytogenet; 2010 Aug; 201(1):48-51. PubMed ID: 20633769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]